The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
CA 19-9 Antigen - an overview | ScienceDirect Topics
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
Common benign HPB conditions with associated deranged CA19.9 level | Download Table
CA19-9 for detecting recurrence of pancreatic cancer | Scientific Reports
Dynamic change of serum CA19–9 levels in benign and malignant patients with obstructive jaundice after biliary drainage and new correction formulas | BMC Cancer | Full Text
Enhanced Discrimination of Malignant from Benign Pancreatic Disease by Measuring the CA 19-9 Antigen on Specific Protein Carriers | PLOS ONE
Serum CA 19-9 and CA 125 as a diagnostic marker in carcinoma of gallbladder Bind MK, Mishra RR, Kumar V, Misra V, Singh PA - Indian J Pathol Microbiol
Non-malignant causes of CA19.9 elevation (medline research) | Download Table
Two Patients with Extremely Elevated Tumor Markers: Where Is the Malignancy?
Should I take a Cancer Marker Test? | Positive Bioscience
Non-malignant causes of CA19.9 elevation (medline research) | Download Table
Combined Evaluation of AFP, CA15-3, CA125, CA19-9, and CEA Tumor Markers in Patients with Hepatitis B and C | Semantic Scholar
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
Diagnostic and prognostic value of carcinoembryonic antigen in pancrea | OTT
Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer - Yang - Journal of Gastrointestinal Oncology
The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice | Science
Persistent elevation of Ca 19-9 and an unexpected finding. A case report | Cirugía y Cirujanos (English Edition)
Tumor Markers in Pancreatic Cancer: 2013
Frontiers | Diagnostic Significance of Serum IgG Galactosylation in CA19-9- Negative Pancreatic Carcinoma Patients
Tumor Markers : All you need to know
Tumor Markers:- Part 7 - CA 125 and CA 19-9 - Labpedia.net